179 related articles for article (PubMed ID: 17556179)
21. Evaluation of myocardial glucose metabolism before and after recovery of myocardial function in patients with tachycardia-induced cardiomyopathy.
Matsumoto K; Takahashi N; Ishikawa T; Sumita S; Matsushita K; Inoue N; Kobayashi T; Uchino K; Kimura K; Inoue T; Umemura S
Pacing Clin Electrophysiol; 2006 Feb; 29(2):175-80. PubMed ID: 16492304
[TBL] [Abstract][Full Text] [Related]
22. Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage: assessment using BMIPP dynamic SPECT with analysis by the Rutland method.
Kitagawa K; Takeda K; Saito K; Okamoto S; Makino K; Maeda H; Ichihara T
J Nucl Med; 2002 Oct; 43(10):1286-94. PubMed ID: 12368365
[TBL] [Abstract][Full Text] [Related]
23. Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging.
Jindal A; Mathur A; Pandey U; Sarma HD; Chaudhari P; Dash A
J Labelled Comp Radiopharm; 2014 Jun; 57(7):463-9. PubMed ID: 24966158
[TBL] [Abstract][Full Text] [Related]
24. Developing a new PET myocardial perfusion tracer.
Jain D; Ghanbarinia A; He ZX
J Nucl Cardiol; 2009; 16(5):689-90. PubMed ID: 19582530
[No Abstract] [Full Text] [Related]
25. Radiosynthesis of N-[(11)C]-methyl-hydroxyfasudil as a new potential PET radiotracer for rho-kinases (ROCKs).
Valdivia AC; Mason S; Collins J; Buckley KR; Coletta P; Beanlands RS; Dasilva JN
Appl Radiat Isot; 2010 Feb; 68(2):325-8. PubMed ID: 19939685
[TBL] [Abstract][Full Text] [Related]
26. Metabolic imaging of patients with cardiomyopathy.
Geltman EM
Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
[TBL] [Abstract][Full Text] [Related]
27. Nuclear cardiology.
Schad N
G Ital Cardiol; 1988 Apr; 18(4):327-32. PubMed ID: 3053309
[No Abstract] [Full Text] [Related]
28. Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Isiguzo M; Brunken R; Tchou P; Xu M; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):50-5. PubMed ID: 21796891
[TBL] [Abstract][Full Text] [Related]
29. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
[No Abstract] [Full Text] [Related]
30. Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid.
Jalilian AR; Akhlaghi M; Mirzaii M; Karimian AR
Nucl Med Rev Cent East Eur; 2006; 9(2):108-13. PubMed ID: 17304472
[TBL] [Abstract][Full Text] [Related]
31. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
Takala TO; Nuutila P; Pulkki K; Oikonen V; Grönroos T; Savunen T; Vähäsilta T; Luotolahti M; Kallajoki M; Bergman J; Forsback S; Knuuti J
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1617-22. PubMed ID: 12458396
[TBL] [Abstract][Full Text] [Related]
32. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
[TBL] [Abstract][Full Text] [Related]
33. Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.
Saito K; Takeda K; Okamoto S; Okamoto R; Makino K; Tameda Y; Nomura Y; Maeda H; Ichihara T; Nakano T
J Nucl Cardiol; 2000; 7(6):553-61. PubMed ID: 11144469
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and preliminary evaluation of 18-(18)F-fluoro-4-thia-oleate as a PET probe of fatty acid oxidation.
DeGrado TR; Bhattacharyya F; Pandey MK; Belanger AP; Wang S
J Nucl Med; 2010 Aug; 51(8):1310-7. PubMed ID: 20660391
[TBL] [Abstract][Full Text] [Related]
35. Clinical roles of perfusion and metabolic imaging.
Tamaki N; Kuge Y; Tsukamoto E
J Cardiol; 2001; 37 Suppl 1():57-64. PubMed ID: 11433829
[TBL] [Abstract][Full Text] [Related]
36. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
37. Validation of (99m)Tc-labeled "4+1" fatty acids for myocardial metabolism and flow imaging: Part 1: myocardial extraction and biodistribution.
Mirtschink P; Stehr SN; Walther M; Pietzsch J; Bergmann R; Pietzsch HJ; Weichsel J; Pexa A; Dieterich P; Wunderlich G; Binas B; Kropp J; Deussen A
Nucl Med Biol; 2009 Oct; 36(7):833-43. PubMed ID: 19720295
[TBL] [Abstract][Full Text] [Related]
38. [Regional assessment of myocardial fatty acid metabolism by PET with 11C-palmitate].
Tamaki N; Kawamoto M; Tadamura E; Konishi J
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):629-35. PubMed ID: 12436593
[No Abstract] [Full Text] [Related]
39. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.
Law WP; Wang WY; Moore PT; Mollee PN; Ng AC
J Nucl Med; 2016 Nov; 57(11):1733-1739. PubMed ID: 27307344
[TBL] [Abstract][Full Text] [Related]
40. Molecular Imaging of PARP.
Carney B; Kossatz S; Reiner T
J Nucl Med; 2017 Jul; 58(7):1025-1030. PubMed ID: 28473593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
